It is appropriate for adults with a BMI of 25 kg/m or greater, indicating overweight, or 30 kg/m or more, indicating obesity, to assist in reaching their weight loss objectives
Your provider can assess your specific medical history, kidney function, and prior medication tolerability to make an informed decision about antibiotic choice and tirzepatide continuation
Learn more PT-141 is a revolutionary peptide that has garnered attention for its potential to enhance sexual desire and function
Following FDA approval in 2024 for moderate-to-severe OSA in patients with obesity, coverage policies are evolving, but patients should verify their specific plan's coverage for OSA, weight management, or diabetes indications as tirzepatide can be costly
A: Semaglutide and Tirzepatide are administered weekly via injection